Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.990
-0.010 (-0.50%)
Aug 28, 2026, 3:59 PM EST
Cannara Biotech Financials Overview
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Revenue Revenue Growth | 117.33 | 107.2 | 81.75 | 57.26 | 35.84 | 17.02 |
Revenue Growth | 14.84% | 31.14% | 42.77% | 59.76% | 110.58% | 567.25% |
Gross Profit Gross Profit Growth | 49.97 | 47.1 | 29.79 | 27.23 | 17.33 | 10.3 |
Operating Income Operating Income Growth | 18.25 | 21.66 | 7.64 | 11.72 | 4.82 | 0.05 |
Net Income Net Income Growth | 10.86 | 13.08 | 6.44 | 6.95 | 2.31 | -1.53 |
Earnings Per Share EPS Growth | 0.11 | 0.14 | 0.07 | 0.08 | 0.03 | -0.10 |
EPS Growth | -35.26% | 100.00% | -10.00% | 195.77% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cannabis Operations Cannabis Operations Growth | 112.77 | 103.02 | 77.63 | 53.48 | 32.61 | 13.97 |
Real Estate Operations Real Estate Operations Growth | 3.93 | 3.84 | 4.02 | 3.59 | 3.37 | 3.12 |
Total Total Growth | 116.7 | 106.86 | 81.65 | 57.07 | 36 | 17.27 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Investments Cash & Investments Growth | 21.81 | 14.36 | 6.62 | 4.27 | 12.11 | 8.16 |
Total Debt Total Debt Growth | 37 | 41.58 | 48.33 | 45.78 | 48.39 | 20.9 |
Net Cash (Debt) Net Cash Growth | -15.19 | -27.22 | -41.71 | -41.51 | -36.28 | -12.74 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.16 | -0.29 | -0.46 | -0.46 | -0.41 | -0.17 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19.42 | 20.01 | 10.68 | 5.91 | -6.08 | -2.09 |
Capital Expenditures CapEx Growth | -13.72 | -6.36 | -7.47 | -9.88 | -15.47 | -31.07 |
Free Cash Flow Free Cash Flow Growth | 5.69 | 13.65 | 3.21 | -3.97 | -21.55 | -33.17 |
Free Cash Flow Growth | -62.01% | 324.86% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Gross Margin | 42.59% | 43.94% | 36.44% | 47.56% | 48.35% | 60.49% |
Operating Margin | 15.55% | 20.20% | 9.35% | 20.46% | 13.45% | 0.31% |
Pretax Margin | 13.87% | 16.88% | 5.49% | 12.13% | 6.43% | -8.98% |
Profit Margin | 9.25% | 12.20% | 7.88% | 12.13% | 6.43% | -8.98% |
FCF Margin | 4.85% | 12.74% | 3.93% | -6.93% | -60.11% | -194.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
PE Ratio | 18.10 | 12.59 | 9.51 | 13.02 | 51.35 | - |
Forward PE | 10.90 | 12.41 | - | - | - | - |
P/FCF Ratio | 34.52 | 12.05 | 19.05 | - | - | - |
PS Ratio | 1.68 | 1.54 | 0.75 | 1.58 | 3.30 | 8.75 |